In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus

BACKGROUND: Vancomycin is drug of choice for treatment of Methicillin Resistant Staphylococcus aureus (MRSA) infections. S. aureus with reduced vancomycin susceptibility (SA-RVS) is on rise. Current guidelines of detection of SA-RVS are based on MIC (Minimum Inhibitory Concentration) by broth or aga...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chaudhari, C.N., Tandel, K., Grover, N., Bhatt, P., Sahni, A.K., Sen, S., Prahraj, A.K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2014
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213919/
https://ncbi.nlm.nih.gov/pubmed/25378772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2013.11.008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller